Loss of MBNL Leads to Disruption of Developmentally Regulated Alternative Polyadenylation in RNA-Mediated Disease

Cited by (290)

Items 201–290 of 290

1. Alternative cleavage and polyadenylation: key regulatory mechanisms in health and disease
   Ying Zhang, Zikun Huang, Weiqing Lu, Zhaoyong Liu · 2025 · RNA Biology
2. Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers
   Juan M. Fernández‐Costa, Beatriz Llamusí, Ariadna Bargiela, Miren Zulaica, Mari Carmen Álvarez-Abril, Manuel Pérez‐Alonso, Adolfo López de Munaín, A López, Ruben D. Artero · 2016 · PLoS ONE
3. RNA binding proteins as mediators of pathological cardiac remodeling
   Pooja Acharya, Sharon Parkins, Michael Tranter · 2024 · Frontiers in Cell and Developmental Biology
4. Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1
   Sawyer M Hicks, Jesus A. Frias, Subodh Kumar Mishra, Marina M. Scotti, Derek R. Muscato, Maria Carmen Valero, Leanne M. Adams, John D. Cleary, Masayuki Nakamori, Eric T. Wang et al. · 2024 · Molecular Therapy — Nucleic Acids
5. MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination
   Charles Frison-Roche, Célia Martin Demier, Steve Cottin, Jeanne Lainé, Ludovic Arandel, Marius Halliez, Mégane Lemaître, Xavière Lornage, Laure Strochlic, Maurice S. Swanson et al. · 2024 · Brain
6. Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy
   Zuzanna Rogalska, Krzysztof Sobczak · 2022 · Molecular Therapy — Nucleic Acids
7. Muscleblind-1 interacts with tubulin mRNAs to regulate the microtubule cytoskeleton in C. elegans mechanosensory neurons
   Dharmendra Puri, Sunanda Sharma, Sarbani Samaddar, Sruthy Ravivarma, Sourav Banerjee, Anindya Ghosh‐Roy · 2023 · PLoS Genetics
8. Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I
   Emma Bondy‐Chorney, Tara E. Crawford Parks, Aymeric Ravel‐Chapuis, Bernard Jean Jasmin, Jocelyn Côté · 2016 · Rare Diseases
9. Coupling of alternative splicing and alternative polyadenylation
   Xueying Zhang, Feiyan Liu, Yu Zhou · 2024 · Acta Biochimica et Biophysica Sinica
10. MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model
    Rong-Chi Hu, Yi Zhang, Larissa Nitschke, Sara J. Johnson, Ayrea E. Hurley, William R. Lagor, Zheng Xia, Thomas A. Cooper · 2025 · Journal of Clinical Investigation
11. Cell Cycle Kinase Polo Is Controlled by a Widespread 3′ Untranslated Region Regulatory Sequence in Drosophila melanogaster
    Marta Oliveira, Jaime Freitas, Pedro Borges Pinto, Ana de Jesus, Joana Tavares, Mafalda Pinho, Rita G. Domingues, Telmo Henriques, Carla S. Lopes, Carlos Conde et al. · 2019 · Molecular and Cellular Biology
12. SET domain containing 2 ( SETD2 ) influences metabolism and alternative splicing during myogenesis
    Hannah J. Wiedner, Eduardo V. Torres, R. Eric Blue, Yi‐Hsuan Tsai, Joel S. Parker, Jimena Giudice · 2022 · FEBS Journal
13. Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies
    Edyta Kościańska, Emilia Kozłowska, Agnieszka Fiszer · 2021 · International Journal of Molecular Sciences
14. An in vivo knockdown strategy reveals multiple functions for circMbl
    Nagarjuna Reddy Pamudurti, Vinay Vikas Konakondla-Jacob, Aishwarya Krishnamoorthy, Reut Ashwal-Fluss, Osnat Bartok, Stas Wüst, Katerina Seitz, Roni Maya, Noam Lerner, Inés Lucía Patop et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
15. CPA-Perturb-seq: Multiplexed single-cell characterization of alternative polyadenylation regulators
    Madeline H. Kowalski, Hans‐Hermann Wessels, Johannes Linder, Saket Choudhary, Austin Hartman, Yuhan Hao, Isabella Mascio, Carol Dalgarno, Anshul Bharat Kundaje, Rahul Satija · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
16. RBFOX2 regulated EYA3 isoforms partner with SIX4 or ZBTB1 to control transcription during myogenesis
    Hannah J. Wiedner, R. Eric Blue, Matheus Sadovsky, Christine A. Mills, Xander H.T. Wehrens, Laura E. Herring, Jimena Giudice · 2023 · iScience
17. TRENDseq—A highly multiplexed high throughput RNA 3′ end sequencing for mapping alternative polyadenylation
    Anton Ogorodnikov, Sven Danckwardt · 2021 · Methods in enzymology on CD-ROM/Methods in enzymology
18. Deregulation of RNA Metabolism in Microsatellite Expansion Diseases
    Chaitali Misra, Feikai Lin, Auinash Kalsotra · 2018 · Advances in neurobiology
19. Functional Polymorphism in Pak1–3′ Untranslated Region Alters Skin Tumor Susceptibility by Alternative Polyadenylation
    Kazuhiro Okumura, Megumi Saito, Eriko Isogai, Yurika Tokunaga, Yoshinori Hasegawa, Kimi Araki, Yuichi Wakabayashi · 2022 · Journal of Investigative Dermatology
20. The Muscleblind-like protein MBL-1 regulates microRNA expression in Caenorhabditis elegans through an evolutionarily conserved autoregulatory mechanism
    Jens Verbeeren, Joana Teixeira, Susana M. D. A. Garcia · 2023 · PLoS Genetics
21. Interrogation of RNA-bound proteome with XRNAX illuminates molecular alterations in the mouse brain affected with dysmyelination
    Marta Sztachera, Weronika K. Stanek, Remigiusz Adam Serwa, Luiza Stanaszek, Michał Smuszkiewicz, Dorota Wronka, Monika Piwecka · 2024 · Cell Reports
22. Altered Behavioral Responses Show GABA Sensitivity in Muscleblind-Like 2-Deficient Mice: Implications for CNS Symptoms in Myotonic Dystrophy
    Kamyra S. Edokpolor, Anwesha Banerjee, Zachary T. McEachin, Jingsheng Gu, Adam Kosti, Juan D. Arboleda, Paul S. García, Eric T. Wang, Gary Jonathan Bassell · 2022 · eNeuro
23. Alternative Transcripts Diversify Genome Function for Phenome Relevance to Health and Diseases
    Shane A. Carrion, Jennifer J. Michal, Zhihua Jiang · 2023 · Genes
24. Rescue of Scn5a mis-splicing does not improve the structural and functional heart defects of a DM1 heart mouse model
    Larissa Nitschke, Rong-Chi Hu, Andrew N. Miller, Thomas A. Cooper · 2024 · Human Molecular Genetics
25. Use of HSALR female mice as a model for the study of myotonic dystrophy type I
    Marc Carrascosa-Sàez, Anna Colom-Rodrigo, Irene González-Martínez, Raquel Pérez-Gómez, Andrea García-Rey, Diego Piqueras‐Losilla, Ana Ballestar, Beatriz Llamusí, Estefanía Cerro-Herreros, Ruben D. Artero · 2025 · Lab Animal
26. Expanded‐repeat‐RNA ‐mediated disease mechanisms in myotonic dystrophy
    Masayuki Nakamori · 2022 · Neurology and Clinical Neuroscience
27. Functional requirement of alternative splicing in epithelial-mesenchymal transition of pancreatic circulating tumor
    Lixing Xiao, Haoxiu Sun, Rui Cheng, Rongrong Yang, Xiyun Jin, Zhaochun Xu, Yideng Cai, Yuexin Yang, Fenglan Pang, Guangfu Xue et al. · 2024 · Molecular Therapy — Nucleic Acids
28. RNA gain-of-function mechanisms in short tandem repeat diseases
    Mackenzie L. Davenport, Maurice S. Swanson · 2024 · RNA
29. Molecular genetics of myotonic dystrophy and the evolution of therapeutic approaches
    Joe Nemoto, Masayuki Nakamori · 2025 · Journal of Human Genetics
30. Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1
    Irene González-Martínez, Estefanía Cerro-Herreros, Marc Carrascosa-Sàez, Andrea García-Rey, Diego Piqueras‐Losilla, Anna Colom-Rodrigo, Nerea Moreno, Mouli Chakraborty, Aline Huguet-Lachon, Anchel González‐Barriga et al. · 2026 · The American Journal of Human Genetics
31. Alternative Splicing and CaV ‐Associated Channelopathies
    Willy Munyao, Md. Mostafizur Rahman, Samuel Sabzanov, Elizabeth H. Chu, Ruizhi Wang, Zhifei Wang, Yong Yu, Matteo Ruggiu · 2025 · Wiley Interdisciplinary Reviews - RNA
32. Reversal of molecular pathology by RNA-targeting Cas9 in a myotonic dystrophy mouse model
    Ranjan Batra, David A. Nelles, Florian Krach, James D. Thomas, Lukasz Snjader, Steven M. Blue, Stefan Aigner, Maurice S. Swanson, Gene Wei-Ming Yeo · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
33. Targeting Toxic Nuclear RNA Foci with CRISPR-Cas13 to Treat Myotonic Dystrophy
    Pornthida Poosala, Sean R. Lindley, Kelly M. Anderson, Douglas M. Anderson · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
34. Ring-finger protein RNF126 promotes prostate cancer progression via regulation of MBNL1
    Xin Mei Jiang, Ji Li, Jiali Zhang, Yulei Zhao, Guoqin He, Xiaohui Yao · 2025 · Scientific Reports
35. 288th ENMC International Workshop. Towards better diagnosing, understanding and treating gastrointestinal symptoms in myotonic dystrophy: extended insights and practical recommendations. 16-18 May 2025, Hoofddorp, the Netherlands
    Saskia Scholten, Janel A. M. Peterson, Lynn B. Orriëns, Luca Pastorelli, Giovanni Meola, Benedikt G. H. Schoser, Hilde M. H. Braakman, Saskia Scholten, Janel Peterson, Lynn Orriëns et al. · 2025 · Neuromuscular Disorders
36. Defined d-hexapeptides bind CUG repeats and rescue phenotypes of myotonic dystrophy myotubes in a Drosophila model of the disease
    Anna Serafina Rapisarda, Ariadna Bargiela, Beatriz Llamusí, Isabel Pont, Roger Estrada‐Tejedor, Enrique García‐España, Ruben D. Artero, Manuel Pérez‐Alonso · 2021 · Scientific Reports
37. Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models
    Nerea Moreno, María Sabater-Arcis, Teresa Sevilla, Manuel Pérez Alonso, Jessica Ohana, Ariadna Bargiela, Ruben D. Artero · 2024 · Biological Research
38. New Kids on the Block: The Emerging Role of YAP/TAZ in Vascular Cell Mechanotransduction
    Karl Swärd, Sebastian Albinsson, Catarina Rippe · 2021 · Cardiac and vascular biology
39. Therapeutical Medicine for Wound Healing
    Muhammad Waqar Mazhar · 2022 · American Journal of Biomedical Science & Research
40. Comparative Analysis of Splicing Alterations in Three Muscular Dystrophies
    Vanessa Todorow, Stefan Hintze, Benedikt G. H. Schoser, Peter Meinke · 2025 · Biomedicines
41. Transcriptome alterations underlying metabolic dysfunction and liver disease in myotonic dystrophy type 1
    Aono Fukumoto, T. Yamanaka, Motoaki Yanaizu, Masayuki Nakamori, Manami Hama, Yoshiaki Yasumizu, Kana Shiotsu, Tsuyoshi Matsumura, Curtis A. Nutter, Tomoya Kubota et al. · 2025 · Human Molecular Genetics
42. TEAMwork: Interplay of Post‐Transcriptional Mechanisms, Epigenetics and Metabolism in (Auto‐)Immunity
    Francesca Rossi, Martin Turner · 2025 · European Journal of Immunology
43. MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility
    Janel A. M. Peterson, Jesus A. Frias, Andrew N. Miller, Krishnakant G. Soni, Yi Zhang, Zheng Xia, John Day, Geoffrey A. Preidis, Thomas A. Cooper · 2025 · Proceedings of the National Academy of Sciences
44. Fitness landscapes of human microsatellites
    Ryan J. Haasl, Bret A. Payseur · 2024 · PLoS Genetics
45. The role of the 3′-UTR of the chemokine receptor CCR2 and hnRNPA0 in regulating mRNA stability and subcellular distribution in human CD4+ T cells
    Yunus Yükselten, Hanan Wishah, Lingyun Wang, Richard E. Sutton · 2025 · Frontiers in Immunology
46. Mammalian Cis-Acting RNA Sequence Elements
    Irina Vlasova-St. Louis, Calandra Sagarsky · 2018 · InTech eBooks
47. Neurodegeneration induces a developmental RNA processing program by calpain-mediated MBNL2 degradation
    Lee‐Hsin Wang, Yu-Mei Lin, Chien‐Yu Lin, Yijuang Chern, Guey‐Shin Wang · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
48. Tumorigenic de-differentiation: the alternative splicing way
    Debleena Ray, David Mark Epstein · 2020 · Molecular & Cellular Oncology
49. MBNL1 Regulates the Expression and Alternative Splicing of Genes Enriched in Cell Adhesion and Apoptosis
    Meijia Liu, Xianjing Song, Longbo Li, Chunli Song, Yongfeng Shi · 2021 · Research Square
50. Pro-inflammatory polarization and colorectal cancer modulate alternative and intronic polyadenylation in primary human macrophages
    Joana Wilton, Filipa Lopes de Mendonça, Isabel Pereira‐Castro, Michael Tellier, Takayuki Nojima, Ângela M. Costa, Jaime Freitas, Shona Murphy, María José Oliveira, Nicholas J. Proudfoot et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
51. Alternative polyadenylation quantitative trait methylation mapping in human cancers provides clues into the molecular mechanisms of APA
    Yige Li, Jingwen Gong, Qingrong Sun, Eu Gene Vong, Xiaoqing Cheng, Binghong Wang, Ying Yuan, Jin Li, Eric R. Gamazon, Dan Zhou et al. · 2024 · The American Journal of Human Genetics
52. Differential pathology and susceptibility to MBNL loss across muscles in myotonic dystrophy mouse models
    Mackenzie L. Davenport, Amaya Fong, Gloria Montoya-Vazquez, Maria Fernanda Alves de Moura, Jodi L. Bubenik, Maurice S. Swanson · 2025 · JCI Insight
53. MBNL proteins in health, disease, and therapeutic applications
    Nikola Musiała, Patryk Konieczny, Patrycja Plewka, Adam Jasiok, Ewa Stępniak-Konieczna · 2026 · Nucleic Acids Research
54. El papel de los RNAs no-codificantes en la patogénesis de la distrofia miotónica tipo 1
    Nadia Mireya Murillo-Melo, Fabiola V. Borbolla‐Jiménez, Óscar Hernández‐Hernández, Jonathan J. Magaña · 2022 · Investigación en Discapacidad
55. MBNL1 and MRTF-A form a positive feedback loop in regulating the migration of esophageal cancer cells
    Chen Liang, Zheng Chang, Ying Luo, Yao Xu, Ao Chen, Tongcun Zhang · 2022 · Journal of Cancer Research and Therapeutics
56. 248th ENMC International Workshop: Myotonic dystrophies: Molecular approaches for clinical purposes, framing a European molecular research network, Hoofddorp, the Netherlands, 11–13 October 2019
    Derick G. Wansink, Geneviève Gourdon, Baziel G.M. van Engelen, Benedikt G. H. Schoser · 2020 · Neuromuscular Disorders
57. miR-1/206 down-regulates splicing factor Srsf9 to promote myogenesis
    Kristen K. Bjorkman, Massimo Buvoli, Emily K. Pugach, Michael M. Polmear, Leslie Anne Leinwand · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
58. SURVEY AND SUMMARY Molecular mechanisms in DM1 – – a focus on foci
    Olof Joakim Pettersson, Lars Aagaard, Thomas Gryesten Jensen, Kroun Damgaard · 2014
59. METHOD Open Access
    Lasse Maretty, Jonas A. Sibbesen, Anders Krogh · 2014
60. Genome-Wide Study of mRNA Isoform Half-Lives
    Joseph V. Geisberg, Zarmik Moqtaderi · 2015 · Methods in molecular biology
61. A Two-Pronged Approach to Preeclampsia: Understanding Gene Expression and Targeting sFlt1 using RNAi
    Ami Ashar-Patel · 2017 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
62. Molecular Defects in the DM Central Nervous System
    Takashi Kimura · 2018 · Springer eBooks
63. Fibroblast State Reversal By MBNL1-Dependent Transcriptome Modification Regulates Cardiac Repair
    Darrian Bugg, Ross C. Bretherton, Kylie E Beach, Anna Reese, Jagadambika J. Gunaje, Galina V. Flint, Cole A. DeForest, April Stempien‐Otero, Jennifer Davis · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
64. Altered drug metabolism and increased susceptibility to fatty liver disease in myotonic dystrophy
    Zachary Dewald, Andrew S. Gupta, Ullas Valiya Chembazhi, Auinash Kalsotra · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
65. MBNL1 and RBFOX1 co-regulate alternative splicing events transcriptome-wide through a conserved buffering mechanism
    Melissa A. Hale, Joseph Ellis, Ryan C. Meng, Sunny McDaniel, Amy E. Mahady, Stacey D. Wagner, Jared I. Richardson, Ona L. McConnell, Eric T. Wang, J. Andrew Berglund · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
66. RNA nucleotide repeats induce mitochondrial dysfunction and the ribosome-associated quality control
    Joana Teixeira, Anu-Mari Harju, Alaa Othman, Ove Eriksson, Ana S. Brandão, Brendan James Battersby, Susana M. D. A. Garcia · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
67. Faculty Opinions recommendation of What are 3' utrs doing?
    Ariel Bazzini, Qiushuang Wu · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
68. circMbl Functions in cis and in trans to Regulate Gene Expression With Impacts on Physiology
    Nagarjuna Reddy Pamudurti, Inés Lucía Patop, Aishwarya Krishnamoorthy, Osnat Bartok, Roni Maya, Noam Lerner, Tsevi Beautus, Sebastián Kadener · 2021 · SSRN Electronic Journal
69. Molecular genetic diagnostics of childhood muscular dystrophies
    Lenka Fajkusová, Jana Zídková · 2022 · Neurologie pro praxi
70. Same same but different : a comprehensive functional analysis of SRSF3 and SRSF7 in the regulation of alternative polyadenylation within the 3’ untranslated region
    Oliver Daniel Schwich · 2021 · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
71. Faculty Opinions recommendation of CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing.
    Irina M. Conboy · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
72. Cpy(a/t)(q/w)e D-Hexapeptides Bind CUG Repeats and Rescue Phenotypes of Myotonic Dystrophy Myoblasts and A Drosophila Model of the Disease
    Ariadna Bargiela, Ruben D. Artero, Roger Estrada‐Tejedor, Anna Serafina Rapisarda, Enrique García‐España, Beatriz Llamusí, Manuel Pérez‐Alonso, Isabel Pont · 2020 · Research Square
73. Role of miRNAs in muscle atrophy: the myotonic dystrophy paradigm
    Anchel González‐Barriga, Ruben D. Artero, A López · 2022 · Elsevier eBooks
74. Musleblind-1 regulates microtubule cytoskeleton in C. elegans mechanosensory neuron through tubulin mRNAs
    Dharmendra Puri, Sarbani Samaddar, Sourav Banerjee, Anindya Ghosh‐Roy · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
75. Bruno 1 regulates cytoskeleton dynamics and a temporal splicing transition to promote myofibril assembly, growth and maturation in Drosophila flight muscle
    Elena V. Nikonova, Marc Canela-Grimau, Christiane Barz, Alexandra Esser, Jessica Bouterwek, Akanksha Roy, Heidemarie Gensler, Martin Heß, Tobias Straub, Ignasi Forné et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
76. Co‐Opting MBNL ‐Dependent Alternative Splicing Cassette Exons to Control Gene Therapy in Myotonic Dystrophy
    Samuel Carrell, Ellie M. Carrell, Ryan C Giovenco, Beverly L. Davidson · 2025 · Annals of Neurology
77. Functions and regulations of RNA-binding proteins in skeletal muscle development and meat production
    Xiaoqin Liu, Gardner Graham, Zhonglin Tang, Honor B. Calnan, Yalan Yang · 2025 · Journal of Integrative Agriculture
78. Contribution of U2AF1, NCBP1 and eIF4A3 to the control of pluripotency maintenance and cell fate determination
    Abdelhamid Mahdi Laaref · 2017 · theses.fr (ABES)
79. The study of the consequences of serca1’s missplicing on muscle function in myotonic dystrophy type 1
    Damily De dea diniz · 2018
80. MBNL derivatives for therapeutic application in myotonic dystrophy
    Magdalena Matłoka · 2019 · theses.fr (ABES)
81. Impasses dans le diagnostic moléculaire des maladies rares : apport d'une meilleure caractérisation fonctionnelle des variants dans le cadre des myopathies et des lipodystrophies héréditaires
    Mathieu Cérino · 2021 · theses.fr (ABES)
82. Étude de la fonction des protéines MBNL au cours du développement à l’aide de cellules souches humaines induites à la pluripotence
    Antoine Mérien · 2021 · theses.fr (ABES)
83. Identification de nouveaux facteurs chimiques capables de moduler l'instabilité des répétitions CTG dans la dystrophie myotonique de type 1
    Laure de Pontual · 2024 · theses.fr (ABES)
84. RNA-binding protein MBNL2 mitigates neuropathic pain after chemotherapy through destabilizing CCR2 expression in primary sensory neurons
    Keshi Yan, Ruining Ma, Bing Wang, Xiaozhou Feng, Xinju Li, Xianglei Meng, Huijie Shang, Benjamin M. Kidd, Maurice S. Swanson, HuiJuan Hu et al. · 2026 · Neurotherapeutics
85. Muscleblind-like proteins dimerize by forming disulfide bonds to regulate alternative splicing and pathogenic RNA foci formation
    Luke A. Knudson, Adam Kosti, Ryan P. Hildebrandt, Ethan Jennings, Eric X Zhou, Kathryn R. Moss, Liang Shi, GiaLinh N. Nguyen, Aleksandra Janusz, Eric T. Wang et al. · 2026 · Nucleic Acids Research
86. MBNL1-mediated alternative splicing in cancer: underlying mechanism, isoform regulation, and translational perspectives
    Huidan Tan, Rongyan Zhao, Bo Liu, Leilei Fu · 2026 · Frontiers in Molecular Biosciences
87. Large-scale tethered screen of RNA-binding proteins reveals novel regulators of poly(A) site selection
    Pratibha Jagannatha, Yoseop Yoon, Samuel B. Landry, Jack T. Naritomi, Lijun Zhan, Sara Olson, Xintao Wei, Lena Annika Street, Liang Liu, Joshua Jeong et al. · 2026 · Molecular Cell
88. Aberrant neuronal differentiation and splicing defects in Congenital Myotonic Dystrophy (DM1) iPSC models
    Surya Chandra Rao Thumu, Jean Patrick M. Gonzales, Soha Munir, Connor Tuck, Oscar Dominguez, S Shyamkishor Singh · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
89. Elimination of myotonia improves myopathy in a muscleblind-like knockout model of myotonic dystrophy
    Matthew T. Sipple, Sakura A. Hamazaki, Vanessa Todorow, Lily A. Cisco, Katherine M Lupia, Christina S. Heil, Peter Meinke, Charles A. Thornton, John D. Lueck · 2026 · Nature Communications
90. MBNL1 hijacks a structured single-stranded distal DNA element to sustain FLT3 expression in KMT2A-rearranged leukemias
    Meixia Che, Shaela Fields, Siqi Yi, Judith W. Hyle, Meng-Li Zhang, Bei-Si Xu, Yong Cheng, Peng Xu, Ya-Jun Jiang, Chun-Liang Li · 2026 · Science Advances